| Mgn Healthcare Services | |
| 6175 Nw 153rd Street Ste 328, Miami Lakes, Florida 33014 | |
| (305) 770-4650 | |
| Name | Mgn Healthcare Services |
|---|---|
| Location | 6175 Nw 153rd Street Ste 328, Miami Lakes, Florida |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 103179 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 33010, 33012, 33013, 33014, 33015, 33016, 33018, 33032, 33035, 33054, 33055, 33056, 33125, 33126, 33127, 33128, 33130, 33134, 33135, 33137, 33139, 33141, 33142, 33143, 33144, 33145, 33147, 33150, 33155, 33157, 33165, 33167, 33172, 33173, 33174, 33175, 33177, 33178, 33183, 33184, 33185, 33186, 33187, 33190, 33193, 33194, 33196 |
| NPI Number | 1538303862 |
| Organization Name | BREWSTER GROUPS, INC. |
| Doing Business As | MGN HEALTHCARE SERVICES |
| Address | 111 Nw 183rd St, Suite 350, Miami, FL 33169 |
| Phone Number | 305-770-4650 |
News Archive
A new article published in the American Journal of Hypertension finds a rising trend in hospitalization for hypertensive emergency with reduction in hospital mortality during the last decade. The presence of acute cardiorespiratory failure, chest pain, stroke, acute chest pain, and aortic dissection were most predictive of higher hospital mortality among other complications.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure). SCCA and ProCure announced the agreement today and are moving the project forward to bring this advanced form of radiation therapy to adult and pediatric cancer patients.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
› Verified 1 days ago
| NPI Number | 1932397262 |
| Organization Name | BREWSTER GROUP INC |
| Doing Business As | MGN HEALTHCARE SERVICES |
| Address | 6175 Nw 153rd St, Suite 328, Miami Lakes, FL 33014 |
| Phone Number | 305-770-4650 |
News Archive
A new article published in the American Journal of Hypertension finds a rising trend in hospitalization for hypertensive emergency with reduction in hospital mortality during the last decade. The presence of acute cardiorespiratory failure, chest pain, stroke, acute chest pain, and aortic dissection were most predictive of higher hospital mortality among other complications.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure). SCCA and ProCure announced the agreement today and are moving the project forward to bring this advanced form of radiation therapy to adult and pediatric cancer patients.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
› Verified 1 days ago
| Quality Rating: |
News Archive
A new article published in the American Journal of Hypertension finds a rising trend in hospitalization for hypertensive emergency with reduction in hospital mortality during the last decade. The presence of acute cardiorespiratory failure, chest pain, stroke, acute chest pain, and aortic dissection were most predictive of higher hospital mortality among other complications.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure). SCCA and ProCure announced the agreement today and are moving the project forward to bring this advanced form of radiation therapy to adult and pediatric cancer patients.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 98.7 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 99.3 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 21.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 27.5 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
A new article published in the American Journal of Hypertension finds a rising trend in hospitalization for hypertensive emergency with reduction in hospital mortality during the last decade. The presence of acute cardiorespiratory failure, chest pain, stroke, acute chest pain, and aortic dissection were most predictive of higher hospital mortality among other complications.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure). SCCA and ProCure announced the agreement today and are moving the project forward to bring this advanced form of radiation therapy to adult and pediatric cancer patients.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 92.5 | 79.6 |
| How often patients got better at getting in and out of bed | 86.6 | 81.1 |
| How often patients got better at bathing | 94.8 | 82.3 |
| How often patients’ breathing improved | 90 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 65.4 | 75 |
| How often home health patients had to be admitted to the hospital | 13.6 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 6.9 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99.1 | 94 |
News Archive
A new article published in the American Journal of Hypertension finds a rising trend in hospitalization for hypertensive emergency with reduction in hospital mortality during the last decade. The presence of acute cardiorespiratory failure, chest pain, stroke, acute chest pain, and aortic dissection were most predictive of higher hospital mortality among other complications.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure). SCCA and ProCure announced the agreement today and are moving the project forward to bring this advanced form of radiation therapy to adult and pediatric cancer patients.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
› Verified 1 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
A new article published in the American Journal of Hypertension finds a rising trend in hospitalization for hypertensive emergency with reduction in hospital mortality during the last decade. The presence of acute cardiorespiratory failure, chest pain, stroke, acute chest pain, and aortic dissection were most predictive of higher hospital mortality among other complications.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure). SCCA and ProCure announced the agreement today and are moving the project forward to bring this advanced form of radiation therapy to adult and pediatric cancer patients.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
› Verified 1 days ago
The patient survey data of Mgn Healthcare Services is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 99 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 100 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 86 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 97 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 93 | 78 |
News Archive
A new article published in the American Journal of Hypertension finds a rising trend in hospitalization for hypertensive emergency with reduction in hospital mortality during the last decade. The presence of acute cardiorespiratory failure, chest pain, stroke, acute chest pain, and aortic dissection were most predictive of higher hospital mortality among other complications.
Prostate cancer patients who are treated with a combination of hormone therapy and radiation have a substantially improved chance of survival compared to patients who do not receive radiation, according to interim results of the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc. (ProCure). SCCA and ProCure announced the agreement today and are moving the project forward to bring this advanced form of radiation therapy to adult and pediatric cancer patients.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved raxibacumab for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.
› Verified 1 days ago
Maximal Trust Health Care, Inc Location: 15715 S Dixie Hwy Ste 307-308, Miami Lakes, Florida 33016 Ratings: NA Phone: (305) 819-2952 | |
South Florida Pediatric Homecare Inc Location: 5793 Nw 151st St Unit 5793b, Miami Lakes, Florida 33014 Ratings: NA Phone: (305) 249-5218 | |
Mgn Healthcare Services Location: 6175 Nw 153rd Street Ste 328, Miami Lakes, Florida 33014 Ratings: Phone: (305) 770-4650 | |
Renacer Home Health Care, Inc. Location: 14750 Nw 77th Ct Ste 108, Miami Lakes, Florida 33016 Ratings: Phone: (305) 817-1800 | |
Care Force Inc Location: 5801 Nw 151 St Ste 304, Miami Lakes, Florida 33014 Ratings: Phone: (305) 362-4980 | |
Professional Home Services, Inc. Location: 6001 Nw 153rd St, Ste 152, Miami Lakes, Florida 33014 Ratings: Phone: (305) 827-1211 |